Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Letters

Impact of COVID-19 on pediatric clinical research in France

Florence Flamein, Frederic Gottrand, Maya Laxmi Patel and Régis Hankard
CMAJ May 25, 2020 192 (21) E589; DOI: https://doi.org/10.1503/cmaj.75416
Florence Flamein
Pediatrician, French Clinical Research Infrastructure Network (F-CRIN) — PEDSTART, Centre Hospitalier Universitaire de Lille, University of Lille, Lille, France
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic Gottrand
Professor of pediatrics, French Clinical Research Infrastructure Network (F-CRIN) — PEDSTART, Centre Hospitalier Universitaire de Lille, University of Lille, Lille, France
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maya Laxmi Patel
Project manager, French Clinical Research Infrastructure Network (F-CRIN) — PEDSTART, University of Tours, Institut National de la Santé et de la Recherche Médicale, Tours, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Régis Hankard
Professor of pediatrics, French Clinical Research Infrastructure Network (F-CRIN) — PEDSTART, University of Tours, Institut National de la Santé et de la Recherche Médicale, Tours, France
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

As stated by Cheng and colleagues,1 temptations to use unproven medications and strategies instead of relying on scientific evidence are high when facing the frightening coronavirus disease 2019 (COVID-19) pandemic. Most medical and scientific communities have reacted promptly to better fight the disease. This is a particular challenge in pediatric clinical research.

PEDSTART (www.pedstart.org/en) is the national network of French pediatric clinical research centres. A task force has been created to gather all national research initiatives and anticipate the consequences of COVID-19 on pediatric clinical research. At present, we have identified no fewer than 15 projects at different stages of maturity involving pediatric patients. Overlap between studies is frequent, and multiplicity of trials may jeopardize a relevant approach. Each pediatric clinical investigation centre had to reorganize itself rapidly, while meeting the triple requirement of limiting travel and contact with patients, protecting hospital staff from infection, and reducing the activity of the hospital to ensure there are enough staff and beds for patients with COVID-19. Negative and positive effects have been observed. Although COVID-19 has strengthened team cohesion and involvement, we have to face a decrease in activity of pediatric clinical research. Supply management of investigational medicinal products and good clinical practices will be challenged by unprecedented adaptations of research infrastructure.

This period may be a chance to merge projects and to join forces to deal with the resumption of “usual” activity, which will be a challenging task in itself. We encourage and support the merging of risk-mitigation activities at an international level to better anticipate and respond to the impact of COVID-19 on ongoing and future pediatric clinical research.

Footnotes

  • Competing interests: None declared.

Reference

  1. ↵
    1. Cheng MP,
    2. Lee TC,
    3. Tan DHS,
    4. et al
    . Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic. CMAJ 2020;192: E405–7.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (21)
CMAJ
Vol. 192, Issue 21
25 May 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of COVID-19 on pediatric clinical research in France
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Impact of COVID-19 on pediatric clinical research in France
Florence Flamein, Frederic Gottrand, Maya Laxmi Patel, Régis Hankard
CMAJ May 2020, 192 (21) E589; DOI: 10.1503/cmaj.75416

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Impact of COVID-19 on pediatric clinical research in France
Florence Flamein, Frederic Gottrand, Maya Laxmi Patel, Régis Hankard
CMAJ May 2020, 192 (21) E589; DOI: 10.1503/cmaj.75416
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • Reference
  • Responses
  • Metrics
  • PDF

Related Articles

  • Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The 5 Ps need an update: toward a comprehensive sexual history
  • Don’t ignore perimenopause
  • Hospital-at-home programs in Canada: challenges and pitfalls
Show more Letters

Similar Articles

Collections

  • Topics
    • Infectious diseases: COVID-19

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire